The company that pioneered the usage of artificial intelligence (AI) in advanced imaging for stroke, embraces AI leadership with a new brand.
MENLO PARK, Calif.--(BUSINESS WIRE)--#AI--iSchemaView, also known as RAPID, the worldwide leader in advanced imaging for stroke, today announced the company is now RapidAI. In 2018, co-founder Dr. Greg Albers presented groundbreaking findings at the International Stroke Conference (ISC) that supported expanded treatment window guidelines for stroke patients. Based on intelligence gained from over 650,000 scans across more than 1,500 hospitals in over 50 countries, the AI-enhanced Rapid platform has become the gold standard for advanced imaging for stroke.
Now on the heels of unprecedented worldwide usage and availability of the Rapid platform, RapidAI is unveiling new branding, a new website, and technology partner news at ISC 2020 (Booth #315).
RapidAI News from ISC 2020 at the Los Angeles Convention Center, Feb 18-21
RAPID becomes RapidAI. The company that leads AI-enhanced stroke imaging around the globe, embraces the future with a new brand and website, RapidAI.com.
RapidAI Launches Technology Partner Program. The RapidAI Technology Partner Program gives customers the flexibility to deploy the Rapid platform and access Rapid results according to their organization’s needs. The program broadens the availability of RapidAI technology in more environments, including Mobile Stroke Units (MSUs) and Angio Suites. It also expands access to RapidAI results through more healthcare communication platforms, and increases the options for deployment and implementation of the Rapid platform—on premise or in the cloud.
RapidAI Product Showcase Highlights at ISC
- The full Rapid advanced imaging platform which includes Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS
- The Rapid Mobile App provides stroke team members fast access to RapidAI results, the ability to preview source files, and communicate about patient care
- Rapid U, the advanced role-based training and certification program for Rapid products
The RapidAI Presentation Theater at the International Stroke Conference 2020
Stop by the RapidAI booth #315. Grab a seat and learn about the latest advancements in comprehensive stroke care from Dr. Greg Albers and other leaders in stroke.
The full schedule of sessions can be found at https://www.rapidai.com/isc2020presentationtheater and include:
- Precision Medicine and the Future of Stroke Care
- Mobile Stroke Units: Conclusive Field Diagnosis and Improved Patient Routing
- Case Study: Suffolk County's Mobile Stroke Units
- Optimizing Workflows for Hyper-Acute Stroke Patients
- Mobilizing Clinical Communications at Enterprise Scale
- Case study: Coordinating and Streamlining Acute Stroke Care Communication
To learn more visit RapidAI at booth #315, and online at RapidAI.com
RapidAI is the worldwide leader in advanced imaging for stroke. Installed in over 1,500 hospitals in more than 50 countries, the Rapid imaging platform, powered by artificial intelligence, includes Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS. RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke patients using clinically proven, data-driven technology. With our validated, trusted platform, developed by stroke experts, clinicians worldwide are improving patient care and outcomes every day. The Rapid platform has been shown to aid in patient selection in both early and late-window clinical stroke trials. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, the results of these trials led to new American Heart Association and American Stroke Association treatment guidelines and have dramatically altered the management of acute stroke around the world. For more information, visit RapidAI.com.